
Sensydia Enrolls First Patient in Pivotal Study of Cardiac Performance System
Study evaluates accuracy of CPS compared to gold-standard right heart catheterization to support FDA submission Sensydia, a medical technology company pioneering non-invasive cardiac assessment, announced